{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:10:26Z","timestamp":1785402626874,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpet.2026.104962","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:40:47Z","timestamp":1783147247000},"page":"104962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Striatal remodeling in Parkinson disease"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-5833","authenticated-orcid":false,"given":"Soren D.","family":"Emerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4577-2659","authenticated-orcid":false,"given":"Chiho","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0106-3236","authenticated-orcid":false,"given":"Sarah C.","family":"Honeycutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-0623","authenticated-orcid":false,"given":"Erin S.","family":"Calipari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpet.2026.104962_bib1","doi-asserted-by":"crossref","DOI":"10.1176\/jnp.14.2.223","article-title":"An essay on the shaking palsy. 1817","volume":"14","author":"Parkinson","year":"2002","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.jpet.2026.104962_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.10115","article-title":"Dopamine miracle: from brain homogenate to dopamine replacement","volume":"17","author":"Hornykiewicz","year":"2002","journal-title":"Mov Disord Off J Mov Disord Soc"},{"issue":"1","key":"10.1016\/j.jpet.2026.104962_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF02157069","article-title":"Occurrence and distribution of dopamine in brain and other tissues","volume":"15","author":"Bertler","year":"1959","journal-title":"Experientia"},{"issue":"4596","key":"10.1016\/j.jpet.2026.104962_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"issue":"3296","key":"10.1016\/j.jpet.2026.104962_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.127.3296.471.a","article-title":"On the presence of 3-hydroxytyramine in brain","volume":"127","author":"Carlsson","year":"1958","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jpet.2026.104962_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1353-8020(98)00012-1","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"4","author":"Ehringer","year":"1998","journal-title":"Parkinsonism Relat Disord"},{"issue":"22","key":"10.1016\/j.jpet.2026.104962_bib7","first-page":"851","article-title":"The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism","volume":"113","author":"Birkmayer","year":"2001","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1016\/j.jpet.2026.104962_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"20","key":"10.1016\/j.jpet.2026.104962_bib9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN Guideline Subcommittee","volume":"97","author":"Pringsheim","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104962_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103788","article-title":"Striatal spinophilin enhances dopamine D2 receptor (D2R) interaction with cytosolic proteins to mediate persistent D2R agonist-induced locomotor suppression","volume":"393","author":"Hens","year":"2026","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.104962_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"43","key":"10.1016\/j.jpet.2026.104962_bib12","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1523\/JNEUROSCI.2891-04.2004","article-title":"Dopamine modulates release from corticostriatal terminals","volume":"24","author":"Bamford","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpet.2026.104962_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"issue":"21","key":"10.1016\/j.jpet.2026.104962_bib14","doi-asserted-by":"crossref","first-page":"14286","DOI":"10.1074\/jbc.M801377200","article-title":"Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model","volume":"283","author":"Brown","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jpet.2026.104962_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jamaneurol.2026.0590","article-title":"Fixed-dose tavapadon for early Parkinson disease: a randomized clinical trial","volume":"83","author":"Pahwa","year":"2026","journal-title":"JAMA Neurol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:21:04Z","timestamp":1785399664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0022356526011614"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104962","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Striatal remodeling in Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104962","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103788","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"104962"}}